LHCSX — Lord Abbett Health Care Fund
Data updated: 2026-06-29
LHCSX — Lord Abbett Health Care Fund data: holdings, portfolio allocation, expenses, performance, cashflows, risk and SEC filings. United States Health Care Equity · $8.15M AUM · 1.03% expense ratio · 16.7% 1-yr return. From SEC regulatory filings.
LHCSX Fund Overview
LHCSX — Lord Abbett Health Care Fund is a US mutual fund managed by Lord Abbett Securities Trust, categorised as United States Health Care Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: Lord Abbett Securities Trust
- Category: United States Health Care Equity
- Assets under management: $8.15M
- 1-year return: 16.7%
- Ticker: LHCSX
- SEC CIK: 0000898031
- SEC series ID: S000064462
- Share class ID: C000208665
LHCSX Holdings
Top 10 holdings of Lord Abbett Health Care Fund by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Eli Lilly & Co | 8.89% |
| AstraZeneca PLC | 4.73% |
| Gilead Sciences Inc | 4.25% |
| Johnson & Johnson | 3.19% |
| Nektar Therapeutics | 3.17% |
| Natera Inc | 2.91% |
| Tarsus Pharmaceuticals Inc | 2.83% |
| Guardant Health Inc | 2.63% |
| Argenx SE | 2.49% |
| Novartis AG | 2.46% |
LHCSX Portfolio Allocation
Asset-class allocation of Lord Abbett Health Care Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 98.2% |
| Cash & Equivalents | 3.7% |
LHCSX Performance
Total returns for LHCSX (as of 2026-08-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | -4.8% |
| 1 year | 16.7% |
| 3 years (annualised) | 5.8% |
| 5 years (annualised) | 2.7% |
LHCSX Risk Information
Risk metrics for LHCSX, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 17.1%
LHCSX Costs and Fees
LHCSX costs about $103 per $10,000 invested per year in fund expenses.
- Net expense ratio: 1.03%
- Gross expense ratio: 3.48%
- Portfolio turnover: 91%
- Brokerage commissions: 7.11 bps of average net assets (SEC N-CEN)
LHCSX Cashflows
Over the 12 months to 2026-04, Lord Abbett Health Care Fund had net outflows of $562.95K, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-04 | −$47.26K |
| 2026-03 | −$36.02K |
| 2026-02 | −$165.97K |
| 2026-01 | −$47.99K |
| 2025-12 | −$22.69K |
| 2025-11 | $12.78K |
LHCSX Debt Constituents
No individual debt constituents are reported in Lord Abbett Health Care Fund's latest SEC N-PORT filing.
LHCSX Prospectus and SEC Filings
Official Lord Abbett Health Care Fund filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Other United States Health Care Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.